Home /
Merck boosts ambitions with innovation-focused strategy Belén Garijo , CEO of Merck , unveils a strategy focused on immunology and vaccines.
Published 6sem · 2 sources ✓ Confirmed Notable
The fact The pharmaceutical group aims for accelerated growth by 2030 through innovation and acquisitions.
This shift marks a turning point after three months leading the French giant.
🔗 2 sources — click a link to read an article on the topic:
Why it matters Cette stratégie reflète les priorités du secteur pharmaceutique face aux défis sanitaires et à la concurrence internationale, avec un impact potentiel sur l'emploi et la recherche en France.
What if you saw the whole news differently? Factae cross-checks hundreds of sources worldwide to keep only the fact, no opinion. Explore the front page. → France · © OpenStreetMap, OpenMapTiles, OpenFreeMap World map → Auto-synthesis from 2 media sources · identified on July 30, 2026